Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

LYKA LABS LTD. - 500259 - Closure of Trading Window

 This is to inform you that pursuant to the NSE circular no. NSE/CML/2019/11 and BSE circular no. LIST/COMP/01/2019-20 read with clause 4 of Schedule B of the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015, in compliance thereof, the trading window for dealing in the Equity shares of the Company for designated persons and their immediate relatives shall remain closed from 01st July, 2020 till 48 hours after the declaration of unaudited Financial results for the First quarter ended on 30th June, 2020 (both days inclusive). This is for your information and record.
29-06-2020
Bigul

LYKA LABS LTD. - 500259 - Confirmation Regarding Non Applicability Of SEBI Circular Dated 26Th November, 2018.

 Pursuant to SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 144 dated 26th November, 2018, regarding fund raising by issuance of Debt Securities by Large Entity and disclosure and compliance thereof by such Large Corporate (LC), we, Lyka Labs Limited hereby confirm that the Company does not meet all the conditions mentioned in clause 2.2 of aforesaid Circular pertaining to the Large Corporate (LC) category.
15-06-2020
Bigul

Annual report for Lyka Labs Ltd. for FY-2020
11-06-2020
Bigul

LYKA LABS LTD. - 500259 - Board Meeting Update

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform you that at the meeting of Board of Directors held today i.e. 10th June 2020, have considered and approved Change in appointed date of Merger of Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited with Lyka Labs Limited as 1st April, 2020 in place of 1st April, 2017. The change in appointed date is subject to approval of NCLT, SEBI, ROC, Ahmedabad and any such statutory authority wherever applicable.
10-06-2020
Bigul

LYKA LABS LTD. - 500259 - Financial Result For F.Y. 2019 20

 Financial Result for F.Y. 2019 20
10-06-2020
Bigul

LYKA LABS LTD. - 500259 - Outcome Of Board Meeting Held On 10Th June 2020

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we hereby inform you that at the meeting of Board of Directors held today i.e. 10th June 2020, have considered and approved: 1. Audited Standalone and Consolidated Financial Results for the Fourth Quarter and Financial Year ended on 31st March, 2020. 2. Change in appointed date of Merger of Lyka Healthcare Limited, a wholly owned subsidiary of Lyka Labs Limited with Lyka Labs Limited as 1st April, 2020 in place of 1st April, 2017. The change in appointed date is subject to approval of NCLT, SEBI, ROC, Ahmedabad and any such statutory authority wherever applicable.
10-06-2020
Bigul

LYKA LABS LTD. - 500259 - Material Disclosure In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015.- SEBI Order Dated 05Th June, 2020 In Respect Of GDR Issue.

 With respect to GDR Issue made in the year 2005, the SEBI passed following order; The Company is restrained from accessing the Securities Market including by issuing prospectus, offer document or advertisement soliciting money from the public and is further prohibited from buying, selling or otherwise dealing in securities, directly or indirectly in any manner, for a period of three years from the date of this order. It is clarified that during the period of restraint, the existing holding of securities of the Noticee including units of mutual funds, shall remain frozen. The copy of order is enclosing for your information.
09-06-2020

COVID-19 restrictions affected sales, created liquidity crunch: Lyka Labs

 "There has been interruption in supply of raw material and packing material to the factory," it added.
05-06-2020
Bigul

LYKA LABS LTD. - 500259 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements), 2015 - Impact Of COVID-19

 Impact of COVID-19
05-06-2020
Bigul

LYKA LABS LTD. - 500259 - Board Meeting Intimation for Board Meeting For Adoption Of Audited Standalone And Consolidated Financial Results For The Fourth Quarter And Financial Year Ended On 31St March, 2020.

 LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2020 ,inter alia, to consider and approve With respect to above we wish to inform you that meeting of Board of Directors is scheduled on Wednesday, 10th June, 2020 for consideration of Audited Standalone and Consolidated Financials Results for the Fourth Quarter and Financial Year Ended on 31st March, 2020. As informed earlier the Trading window is closed from 31st March, 2020 till 48 hours after declaration of Financial Results for the quarter and year ended 31st March, 2020 (both days inclusive). Kindly take a note of the same.
03-06-2020
Next Page
Close

Let's Open Free Demat Account